ESG at Chugai
Chugai conducts its business activities to fulfill its mission of benefiting the medical community and human health around the world.
In the capital markets in recent years, interest has grown in non-financial information such as environmental, social and governance (ESG) factors as an essential viewpoint for evaluating a company’s long-term sustainable growth potential.
For Chugai, which is engaged in business related to the important social issue of health, ESG is inextricably linked with the long-term fulfillment of its mission. Chugai believes that medium- to long-term value creation will become possible through the continuous strengthening of the ESG activities.
Supplementary Materials for ESG Related Information [PDF 950KB]
Supplementary Materials for ESG Related Information (2) [PDF 2.5MB]
Supplementary Materials for ESG Related Information (3) [PDF 588KB]
Supplementary Materials for ESG Related Information (4) [PDF 626KB]
Environmental
1Global Environment
As a healthcare company, Chugai is engaged in many scientific and specialized activities, and has a considerable role to play in protecting the environment, which we regard as an important foundation underpinning all of our business activities. Accordingly, we have set priority items and mid- to long-term targets, not only to promote the sustainable growth of our business, but also to protect the environment of the communities where we operate, and the planet as a whole. We are working toward these targets as a company-wide endeavor.
Environmental Management System
Climate Change Countermeasures
Climate change countermeasures are increasingly coming into focus as an important issue worldwide. With an expected strengthening of fluorocarbon regulations, efforts which are simply an extension of previous initiatives have their limits, making an even higher level of initiatives essential. Chugai will implement long-term and large-scale climate change measures to achieve its long-term goal of zero CO2 emissions with 2050 as the final year.
Also, Chugai conducted scenario analysis based on the Task Force on Climate-related Financial Disclosures (TCFD) recommendations. Through the analysis, we will work to address climate change risks and opportunities and engage in further improvement of disclosure.
- Climate Change Countermeasures (Reducing GHG Emissions, Reducing Energy Consumption, Discontinuation of / Conversion from Halogenated Hydrocarbons, Introduction of Eco-friendly cars)
- Disclosures based on the TCFD recommendations
- Sustainability Policy and Data (Environmental Performance)
- 1. Thermal equivalent values of Energy Consumption and CO2 Emissions by Year
- 2. Thermal equivalent values of Energy Consumption and CO2 Emissions by Site or Facility
- 3. Renewable Energy Consumption by Year
- 4. Purchase volume of Green Power Certificates and Non-Fossil Fuel Certificates, by year
- 5-1. Greenhouse Gases Emissions in 2022
- 5-2. GHG Emissions by Year
Use of Renewable/Recycled Resources
With the emphasis on a circular economy, we not only need to fulfill certain obligations, but work to make more dynamic, effective use of resources. Efforts aimed at zero emissions of waste are essential, but at the same time we are designing Chugai’s own business activities to be compatible with a circular economy. In addition, while our business activities are conducted primarily in Japan and thus are characterized by relatively low water risks, given the increased demand from outside, we will be engaging in rigorous risk assessment and management.
- Use of renewable/recycled resources (Waste Reduction, Initiatives involving Chugai product countermeasures to address reduction of environmental load, Water Pollution Prevention and Associated Measures)
- Sustainability Policy and Data (Environmental Performance)
- 6. Annual Industrial Waste Generation
- 8. Annual Water Withdrawal and Wastewater
- 9. Annual Total BOD
- 10. 2022 Water stress, Water withdrawals and Wastewater by Site or Facility
- 11. 2022 A number of sites and water withdrawals by sites at water stress area
- 12. 2022 Total BOD by Site or Facility
- 13. 2022 Total air pollutant by Site or Facility
- 14. Use of Specified Containers and Packaging under the Law for Promotion of Sorted Collection and Recycling of Containers and Packaging
Protection of Biodiversity
Work is needed to not only strengthen handling of PRTR target substances and management of specially controlled industrial waste, but to address the list of substances of very high concern (SVHCs) under the REACH regulation. Chugai will strengthen efforts in wastewater management and in reducing chemical substances, including validation of product manufacturing plans, while also enhancing our efforts to work with local communities.
- Protection of Biodiversity (Chemical Substance Management, Air Pollution Prevention and Associated Measures, Soil Pollution Prevention and Associated Measures, Reducing the use of chemical substances, Reducing hazardous waste, Coexistence with Nature and Protection of Biodiversity)
- Sustainability Policy and Data (Environmental Performance)
- 6. Annual Industrial Waste Generation
- 7. Handled Amounts of Chemical Substances Covered by PRTR Law (April – March)
Social
2Sustainable Healthcare
As a result of advances in life science and digital technologies, the challenges in healthcare are becoming more sophisticated, diverse and complex. At the same time, growth and aging of populations are expected to put serious financial strains on healthcare systems. To realize its goal of “advanced and sustainable healthcare,” Chugai will pursue continuous innovation and further develop its business activities to help build the mechanisms for achieving that goal while sharing value with its various stakeholders.
Creation of Innovative Drugs and Services
Provision of Solutions for Patients
Adverse Event Management
Quality Assurance and Stable Supply of Products
3Human Rights
Chugai believes that a culture of respect for human rights is a cornerstone for a company to be recognized as a member of society and to earn trust. Therefore, we declare our respect for human rights in the Chugai Group Code of Conduct.
To address human rights issues, which are taking on greater significance as a social issue, Chugai believes that initiatives throughout the entire supply chain as well as within the Chugai Group are important. As such, we have reinforced our measures for respecting human rights, including formulation of the Chugai Group Human Rights Statement and educational activities.
Safety of Clinical Trial Subjects
4Human Resources
At Chugai, we consider our people to be our greatest asset in achieving growth while delivering social value, and consider talent management to be a key management theme. Through our efforts to strengthen talent management to match the right person with the right job, secure diverse human resources by promoting diversity and inclusion (D&I), respect different values and ideas, and maintain a work environment that enables work-life synergy for each and every employee, we strive to foster an organizational culture in which employees can perform to their full potential in their respective roles and continuously innovate while supporting each other’s success.
Employee Job Satisfaction
Development of Employee Potential
Diversity and Inclusion
5Social Contribution
Contribution to society is an important part of the Chugai Group Code of Conduct (CCC). We recognize our role and responsibility as a good corporate citizen, and engage in social contribution activities while maintaining partnerships with communities and society. We also encourage and support the social contribution activities of individual employees.
Social Contribution Activities
Access to Healthcare
The Chugai Group upholds its mission “Dedicate ourselves to adding value by creating and delivering innovative products and services for the medical community and human health around the world.”
As part of this mission, Chugai considers it a duty to contribute to global health by continuously creating new products for unmet medical needs, and working to improve access to healthcare.
Governance
6Governance
Chugai manages its business with a focus on innovation to achieve its mission, based on its unique business model. Chugai is a member of the Roche Group while maintaining its managerial autonomy and independence as a separate listed company. Recognizing the importance of its role in increasing corporate value, Chugai continuously examines and improves corporate governance by both creating systems and mechanisms for corporate governance, and raising its effectiveness.
Corporate Governance
- Mission Statement and Chugai Group Code of Conduct
- Sustainability and Business Strategy
- Basic Approach
- Directors & Officers
- Introduction of Outside Perspectives
- Auditing System and Internal Control System
- Officer Remuneration
- Policy regarding the strategic shareholdings
- Corporate Governance report and related materials
- Messages from the Chairs of the Committees
Risk Management
Corporate activities are affected by various uncertainties (risks) that exist internally and externally. Proper management of risks is therefore essential in maintaining and increasing corporate value. At Chugai, risk management is a key issue underpinning sustainability, and we strive to evolve it every day.
Disclosure and Engagement
Personal Information Protection and Information Security
7Ethics and Compliance
In keeping with its basic philosophy, whereby corporate ethics take priority over profit, Chugai places paramount importance on respect for life and strives for fair and transparent corporate activities based on high ethical standards, along with a commitment to scientific excellence. We view compliance as not only complying with laws, but also meeting expectations from society. Therefore, we are enhancing compliance training for employees, conducting monitoring surveys and implementing compliance risk mitigation measures to achieve a higher level of compliance.
Compliance
- Framework for Promoting Sustainability
- Initiatives for Ethics and Compliance
- Guidelines on Relation with Medical Institutions and Patient Groups
- Policy and Initiatives for Bioethics and Animal Welfare (Biotechnology Policies, Policy on Research Using Human Stem Cells, Policy for Research by Animals)
Code of Conduct
Fair Transactions
- In order to eliminate unlawful acts in pursuit of immediate benefits and unethical acts that abuse loopholes, Chugai prohibits bribery, graft, and other corrupt acts in the Chugai Group Code of Conduct. Specifically, we work to prevent corruption and bribery in accordance with the Anti-Bribery Policy and the Chugai Ethical Purchasing Standards.
- Chugai Group Code of Conduct
- Global Anti-Bribery Policy (an excerpt)[PDF 53KB]
- Chugai Ethical Purchasing Standards (Measure, Purchasing Policy and Chugai Ethical Purchasing Standards)
8Supply Chain Management
Supply chains are becoming increasingly important against the backdrop of technological advances, changes in the social structure, and rising expectations and requirements for pharmaceutical companies. At Chugai, in addition to optimizing purchasing and building sound relationships with business partners, we are promoting the evolution of our supply chain management by conducting comprehensive supplier evaluations that include aspects such as the natural environment, work environment and human rights in order to solve social issues in cooperation with suppliers.
